Paul E. Verweij

机构：Radboud University Nijmegen, Universität Innsbruck, University Medical Center, Radboud University Medical Center, National Institute for Public Health and the Environment, Radboud Institute for Molecular Life Sciences · ORCID：0000-0002-8600-9860

发表论文 741 篇 · 总被引 50632 次 · h-index 112

代表论文

• Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study (2025 · The Lancet Infectious Diseases · 被引 73)
• Aspergillus fumigatus biology, immunopathogenicity and drug resistance (2025 · Nature Reviews Microbiology · 被引 45)
• Triazole-resistant Aspergillus fumigatus in the Netherlands between 1994 and 2022: a genomic and phenotypic study (2025 · The Lancet Microbe · 被引 20)
• Widely dispersed clonal expansion of multi-fungicide-resistant Aspergillus fumigatus limits genomic epidemiology prospects (2025 · mBio · 被引 12)
• Azole fungicides and Aspergillus resistance, five EU agency report highlights the problem for the first time using a One Health approach (2025 · npj Antimicrobials and Resistance · 被引 6)
• Influenza-associated invasive aspergillosis in the ICU: a prospective, multicentre cohort study (2025 · Critical Care · 被引 4)